Effect of heparin and plasminogen inhibitor (EACA) in brief and prolonged treatment on intravenously injected tumour cells.
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D006493:Heparin / Q000494:pharmacology*; D008113:Liver Neoplasms / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D009362:Neoplasm Metastasis / Q000473:pathology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009360:Neoplastic Cells, Circulating; D012208:Rhabdomyosarcoma / Q000139:chemically induced*
D000614:Aminocaproates; D008748:Methylcholanthrene; D006493:Heparin